Zimmer Biomet Holdings, Inc. (NYSE:ZBH) – Research analysts at Gabelli cut their FY2017 earnings per share estimates for Zimmer Biomet Holdings in a research note issued on Thursday. Gabelli analyst J. Tsai now anticipates that the medical equipment provider will post earnings per share of $8.05 for the year, down from their previous estimate of $8.25. Gabelli has a “Buy” rating and a $142.00 price objective on the stock. Gabelli also issued estimates for Zimmer Biomet Holdings’ FY2018 earnings at $8.50 EPS, FY2019 earnings at $9.30 EPS, FY2020 earnings at $10.20 EPS and FY2021 earnings at $11.20 EPS.

Several other research analysts have also weighed in on the company. Zacks Investment Research lowered Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Monday. Stifel Nicolaus reaffirmed a “hold” rating and issued a $120.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday. Jefferies Group LLC reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday. Morgan Stanley cut their target price on Zimmer Biomet Holdings from $146.00 to $136.00 and set an “overweight” rating on the stock in a research report on Thursday, November 2nd. Finally, BMO Capital Markets cut their target price on Zimmer Biomet Holdings from $140.00 to $135.00 and set an “outperform” rating on the stock in a research report on Thursday, November 2nd. Four research analysts have rated the stock with a sell rating, eight have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. Zimmer Biomet Holdings currently has an average rating of “Hold” and an average price target of $134.75.

COPYRIGHT VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) to Post FY2017 Earnings of $8.05 Per Share, Gabelli Forecasts” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/zimmer-biomet-holdings-inc-zbh-to-post-fy2017-earnings-of-8-05-per-share-gabelli-forecasts/1684040.html.

Zimmer Biomet Holdings (ZBH) opened at $109.34 on Monday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78. The firm has a market capitalization of $22,089.90, a price-to-earnings ratio of 13.54, a P/E/G ratio of 1.61 and a beta of 1.17. Zimmer Biomet Holdings has a 52-week low of $95.63 and a 52-week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.74 by ($0.02). The firm had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Zimmer Biomet Holdings had a return on equity of 16.29% and a net margin of 8.36%. The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same period last year, the business posted $1.79 earnings per share.

Institutional investors have recently made changes to their positions in the company. Bronfman E.L. Rothschild L.P. grew its stake in Zimmer Biomet Holdings by 25.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in Zimmer Biomet Holdings by 3.9% in the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after purchasing an additional 33 shares in the last quarter. IHT Wealth Management LLC grew its stake in Zimmer Biomet Holdings by 28.4% in the first quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 256 shares in the last quarter. BB&T Investment Services Inc. acquired a new position in Zimmer Biomet Holdings in the second quarter worth about $144,000. Finally, Sandy Spring Bank grew its stake in Zimmer Biomet Holdings by 5.4% in the second quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 66 shares in the last quarter. Institutional investors own 85.80% of the company’s stock.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Earnings History and Estimates for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.